All treatments
Treatment
Amivantamab Intravenous clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruitingPHASE3
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
This study is comparing two ways of giving a medicine called amivantamab for advanced lung cancer. One is through a drip, and the other is a new injection under the skin. We want to see if the injection is easier and quicker for patients.
For: Advanced or Metastatic Non-small Cell Lung CancerUnited States · Argentina · Australia - RecruitingPHASE2
Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
This study is looking at giving a new treatment called amivantamab, sometimes with chemotherapy, before surgery for a certain type of lung cancer. It aims to see if this approach is practical and helpful for patients with specific gene changes in their cancer.
For: Lung Cancer (NSCLC)Belgium · Germany · Netherlands